Cargando…

Rituximab in steroid-refractory immune-related pancreatitis: a case report

The use of immune checkpoint inhibitors (ICIs) for treating several types of cancer is increasing, but they may be associated with immune-related adverse events (irAEs). Pancreatitis is a rare irAE, mostly responsive to steroid treatment. There are no published data on the management of steroid-refr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santoro, Armando, Masini, Silvia, Cavina, Raffaele, Tronconi, Maria Chiara, De Vincenzo, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425594/ https://www.ncbi.nlm.nih.gov/pubmed/37588091 http://dx.doi.org/10.3389/fonc.2023.1205720

Ejemplares similares

Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
por: Gérard, Alexandre, et al.
Publicado: (2020)

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis
por: Tronconi, Maria Chiara, et al.
Publicado: (2020)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome
por: Sinha, Rajiv, et al.
Publicado: (2020)

Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
por: Batra, Chandar M, et al.
Publicado: (2021)

Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib
por: Xing, Qian, et al.
Publicado: (2022)

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment
por: Deng, Dao-Xing, et al.
Publicado: (2022)

Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis
por: Townsend, Matthew J., et al.
Publicado: (2023)

Steroid-Refractory Chronic Idiopathic Thrombocytopenic Purpura Responding to Combination Therapy With Eltrombopag and Rituximab
por: Ahmed, Mohanad, et al.
Publicado: (2020)

Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
por: Di Giorgio, Cristina, et al.
Publicado: (2023)

Rapid Improvement Following Receipt of Infliximab in Steroid-refractory Durvalumab-Associated Grade 3 Pneumonitis
por: Huang, Sherri, et al.
Publicado: (2022)

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil
por: Green, Sarah, et al.
Publicado: (2016)

Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
por: Ahmed, Eyad, et al.
Publicado: (2021)

Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report
por: Hines, Jacobi, et al.
Publicado: (2021)

The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity
por: Xing, Hui, et al.
Publicado: (2023)

Toward the establishment of guidelines for the treatment of steroid‐refractory immune‐related hepatotoxicity
por: Yoshio, Sachiyo
Publicado: (2023)

Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
por: Tomsitz, Dirk, et al.
Publicado: (2023)

Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy
por: Woo, Timothy, et al.
Publicado: (2023)

Steroid-refractory immune related hepatitis may hide viral re-activation
por: Citarella, Fabrizio, et al.
Publicado: (2020)

Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report
por: Onishi, Sachiyo, et al.
Publicado: (2020)

Rituximab for refractory granulomatous eye disease
por: Lower, Elyse E, et al.
Publicado: (2012)

Utilization of Rituximab for Refractory Rowell Syndrome
por: Singh, Sukhraj, et al.
Publicado: (2021)

Efficacy of rituximab in refractory polyarteritis nodosa: a case report
por: Boukhris, Iméne, et al.
Publicado: (2023)

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
por: Nikitin, Eugene, et al.
Publicado: (2023)

Intravenous Steroids for Refractory Chemotherapy-Related Diarrhea: A Case Report
por: Patel, Kishan, et al.
Publicado: (2023)

Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
por: Jung, Chul Won, et al.
Publicado: (2016)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
por: Zucali, Paolo Andrea, et al.
Publicado: (2020)

A Rare Presentation of Concomitant Lung Disease and Hepatitis After Rituximab Treatment: A Case Report
por: Albusoul, Linda, et al.
Publicado: (2023)

Combination therapy of rituximab and corticosteroids for patients with refractory chronic immune thrombocytopenic purpura: report of two cases
por: Ling, Yun, et al.
Publicado: (2013)

Pulse corticosteroid therapy in the treatment of steroid-refractory immune checkpoint inhibitor-related pneumonitis: Case report and review
por: Lai, Kuan-Chang, et al.
Publicado: (2022)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer
por: Li, Lincheng, et al.
Publicado: (2022)

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia
por: Giglio, Fabio, et al.
Publicado: (2023)

D1 MTE1 Case 1: Steroid refractory insulin autoimmune syndrome treated with rituximab and continuous glucose monitoring
por: Batra, Chandar M, et al.
Publicado: (2022)

Intravenous Immunoglobulin and Methylprednisolone Refractory Multisystem Inflammatory Syndrome in Children (MIS-C) in Steroid-Dependent Nephrotic Syndrome Following Rituximab
por: Pal, Priyankar, et al.
Publicado: (2022)

Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
por: Beattie, Jason, et al.
Publicado: (2021)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_969u0drkaajqgv0lqe8k8vhm0l